Sterisets recalls some batches of Steriflush prefilled water syringes after plant inspection
Sterisets Manufacturing S.A. is withdrawing selected batches of Steriflush prefilled water syringes from distribution and use. The decision followed the detection of irregularities during an inspection of the production plant.

© Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych
- 0views
- 0likes and saves
- 0skips
In brief
- Sterisets Manufacturing S.A. is withdrawing from the market and from use selected batches of Steriflush prefilled saline syringes.
- Six catalogue numbers are covered, and the reason is irregularities found during an inspection of the manufacturing facility.
- The withdrawal applies to the sale and use of the products, and details for healthcare facilities are in the FSCA 2026/03 notice.
Which products are covered by the withdrawal
Sterisets Manufacturing S.A. has issued a safety notice designated FSCA 2026/03 (Safety notice (FSCA 2026/03) from Sterisets Manufacturing S.A. concerning the withdrawal from the market and from use of certain batches of Steriflush prefilled saline syringes, REF: 14313BS, 14313BSNS, 14314BSNS, 3040002, 3040006, 3040012, issued due to irregularities found during an inspection of the manufacturing facility – Office for Registration of Medicinal Products, Medical Devices and Biocidal Products). It concerns the withdrawal from the market and from use of selected batches of Steriflush prefilled saline syringes.
Reason for the decision
As the notice states, the withdrawal was undertaken due to irregularities found during an inspection of the manufacturing facility. The notice was published by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. The publication date is 19 November 2026.
What healthcare facilities and users should do
The withdrawal covers both the distribution of these products and their use. This means the listed batches should not be sold or administered to patients. Detailed instructions for healthcare facilities are contained in the notice itself, which should be consulted before taking further steps.
What patients should watch for
If a patient or their family has packaging with the listed catalogue numbers at home or in a facility, it is worth checking whether the number matches the notice. If in doubt about treatment, consult a doctor or pharmacist. In case of a health threat, call 112 or go to the emergency department (SOR).
Read also
- Withdrawal of BS-MTI ureteral stent sets with EPflex wire
- Stryker Spine withdraws 51 batches of the ES2 Nitinol spinal system with blunt Kirschner wire
Sources
Discussion0
- No comments from this perspective yet. Be the first.